Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...
SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration ...
Currently, terminally ill Montanans can obtain life-ending prescriptions under a legal loophole. One bill to ban the practice ...
EQT Foundation opens applications for deeptech solutions tackling female-specific health challenges worldwide, with a focus on funding breakthrough scientific innovationThe grants program will ...
But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...
In a complex maritime rescue operation off Gqeberha's coast, NSRI teams successfully saved a Filipino crewman who had fallen ...
Positive results from Phase 3 trial for MaaT013 in acute Graft-versus-Host disease (aGvHD); topline results (January 2025) showed a 62% gastrointestinal overall response rate at Day 28 and 1-year ...
Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human ...
QRL-101 is designed to open Kv7.2/7.3 ion channels, which work as gates for potassium in nerve cells and help control their ...
It also provides QALSODY for the treatment of Amyotrophic Lateral Sclerosis (ALS); TEGSEDI for the treatment of ATTRv-PN in adults; and WAYLIVRA for treatment for FCS and familial partial ...
By Guest Columnist Dr. Stephanie Duguid Our most recent speaker through the Mississippi Health Ambassador Initiative was Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results